Welcome
to Fintepla.eu
This site is intended for a European audience.
To enter the site, please select from the following options:
Adverse events should be reported. Please refer to section 4.8 of the SmPC for national reporting requirements in your country.
Adverse events should also be reported to Zogenix International Limited on +44 (0)800 060 8767 or email medinfo.eu@zogenix.com
This site is intended for a European audience.
To enter the site, please select from the following options:
Strictly necessary cookies allow to maintain the safety and security of the website, and enable basic features, such as authenticating account users, or allowing you to sign in securely. You can set your browser to block or alert you about these cookies, but some parts of the website will not then work.
Functional cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. Functional cookies are optional. If you do not allow these cookies then some or all of these services may not function properly.
Analytics cookies are used to collect information about how visitors use the website, including which pages you visit, and whether you experience any errors. These cookies use aggregate information to provide statistics on how the website is used and measure traffic, improve website functionality and experience, and optimize content according to the interests and preferences of the users. Analytics cookies are optional. Choosing not to be tracked by these cookies does not affect your navigation experience.